{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihcvo3u6hpurx2es5wt76wkjfvzsswjt5likoqibvxh3rri6ogdp4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mg3yaphbhzx2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreico57q6gvkwefrpwjhu4u7sjpte4hiksae3zoil2xhm65e2gbw2vm"
    },
    "mimeType": "image/jpeg",
    "size": 131432
  },
  "path": "/news/2026-03-petct-early-treatment-response-rheumatoid.html",
  "publishedAt": "2026-03-02T12:40:01.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Arthritis & Rheumatism"
  ],
  "textContent": "A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research published in The Journal of Nuclear Medicine. Compared to the three to six months currently required to establish treatment efficacy, this new imaging technique could help determine the patients who are most likely to respond sooner, allowing non-responders to pursue more effective therapies.",
  "title": "Targeted PET/CT predicts early treatment response in rheumatoid arthritis patients"
}